An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paedi
about
Influenza prevention and treatment in transplant recipients and immunocompromised hostsAssessment of antigen-specific and cross-reactive antibody responses to an MF59-adjuvanted A/H5N1 prepandemic influenza vaccine in adult and elderly subjects.Differential influenza H1N1-specific humoral and cellular response kinetics in kidney transplant patients.Seroconversion of 2009 pandemic influenza A (H1N1) vaccination in kidney transplant patients and the influence of different risk factors.Immunogenicity and safety of cell-derived MF59®-adjuvanted A/H1N1 influenza vaccine for childrenImpact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients.Influenza A/H1N1 vaccine in patients treated by kidney transplant or dialysis: a cohort studyPoor seroprotection but allosensitization after adjuvanted pandemic influenza H1N1 vaccine in kidney transplant recipients.Aflunov®: a vaccine tailored for pre-pandemic and pandemic approaches against influenza.Immunogenicity of pandemic influenza A H1N1/2009 adjuvanted vaccine in pediatric solid organ transplant recipients.Influenza vaccine immunogenicity in patients with primary central nervous system malignancy.Influenza vaccination in the organ transplant recipient: review and summary recommendations.Adjuvanted influenza vaccines.AS03- and MF59-Adjuvanted Influenza Vaccines in Children.
P2860
Q27011595-9996B600-27CC-422A-B475-EDDB091A5EE4Q30223941-2BE5162B-67B7-4C9C-A355-F9E315A87814Q30353821-CD2C4637-830A-4E3B-ACE2-7BDE8A7D8C7FQ30354634-66C1EF0E-29B9-470C-9293-7C1A09E26948Q30371111-5C69FAB5-1ACF-4107-A1BF-73885A82B511Q30372284-D2C82311-8157-4864-8FD8-C0559B053BA1Q30407134-5B19BC61-265A-4D80-9424-B558E0E4AAA7Q30421507-17F0CC28-D72C-4699-B690-C1DCC21632C1Q30424161-EB1272C1-D246-4D42-BE9A-BED1211DB7EFQ30430823-4E197E4F-4F56-4713-A5AA-B24877B19A53Q34511678-67063462-6AD0-47D0-ACE0-2781CFD3AC73Q37940524-FF6F4D56-1330-44FD-97FA-BF7B4D7CDD3CQ37976540-586724D2-4AD6-43A6-934E-A1784725929AQ47658890-C0EA0742-C728-4F9E-8714-21537077B02B
P2860
An open-label, randomized clinical trial assessing immunogenicity, safety and tolerability of pandemic influenza A/H1N1 MF59-adjuvanted vaccine administered sequentially or simultaneously with seasonal virosomal-adjuvanted influenza vaccine to paedi
description
2010 nî lūn-bûn
@nan
2010 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
An open-label, randomized clin ...... ted influenza vaccine to paedi
@ast
An open-label, randomized clin ...... ted influenza vaccine to paedi
@en
type
label
An open-label, randomized clin ...... ted influenza vaccine to paedi
@ast
An open-label, randomized clin ...... ted influenza vaccine to paedi
@en
prefLabel
An open-label, randomized clin ...... ted influenza vaccine to paedi
@ast
An open-label, randomized clin ...... ted influenza vaccine to paedi
@en
P2093
P2860
P50
P356
P1476
An open-label, randomized clin ...... c kidney transplant recipients
@en
P2093
Antonia Valzano
Carlotta Galeone
Cristina Daleno
Domenico Serra
Elisa Meregalli
Luciana Ghio
Nicola Principi
P2860
P304
P356
10.1093/NDT/GFQ657
P407
P577
2010-10-25T00:00:00Z